The 5-HT(2C/2B) receptor agonist, m-chlorophenylpiperazine, increases plasma glucagon levels in rats.
暂无分享,去创建一个
[1] K. Fone,et al. Distribution of the 5‐hydroxytryptamine2C receptor protein in adult rat brain and spinal cord determined using a receptor‐directed antibody: Effect of 5,7‐dihydroxytryptamine , 1997, Synapse.
[2] G. Curzon. Serotonin and Appetite , 1990, Annals of the New York Academy of Sciences.
[3] Y. Sugimoto,et al. Effects of the 5-HT2C/2B receptor agonist 1-(3-chlorophenyl) piperazine on plasma glucose levels of rats. , 1996, European journal of pharmacology.
[4] D. Laude,et al. Evidence that the 5-HT1A receptor agonists buspirone and ipsapirone activate adrenaline release in the conscious rat. , 1990, European journal of pharmacology.
[5] G. Kennett,et al. Potencies of antagonists indicate that 5‐HT1C receptors mediate 1–3(chlorophenyl)piperazine‐induced hypophagia , 1991, British journal of pharmacology.
[6] D. Murphy,et al. Different serotonin receptors mediate blood pressure, heart rate, plasma catecholamine and prolactin responses to m-chlorophenylpiperazine in conscious rats. , 1989, The Journal of pharmacology and experimental therapeutics.
[7] G. Kennett,et al. Evidence that mCPP may have behavioural effects mediated by central 5‐HT1C receptors , 1988, British journal of pharmacology.
[8] G. Kennett,et al. m-CPP: a tool for studying behavioural responses associated with 5-HT1c receptors. , 1990, Trends in pharmacological sciences.
[9] B. Ahrén,et al. α1- and α2-adrenoceptor activation increases plasma glucagon levels in the mouse , 1987 .
[10] A. Kelley,et al. Enhanced reward‐related responding following cholera toxin infusion into the nucleus accumbens , 1997, Synapse.
[11] G. Martin,et al. 5-HT Receptor Classification and Nomenclature: Towards a Harmonization with the Human Genome , 1997, Neuropharmacology.
[12] F. Blaney,et al. 5-HT2 receptor subtypes: a family re-united? , 1995, Trends in pharmacological sciences.
[13] D. Laude,et al. Effects of the 5-HT1C/5-HT2 receptor agonists DOI and α-methyl-5-HT on plasma glucose and insulin levels in the rat , 1990 .
[14] Y. Sugimoto,et al. The effects of the serotonin1A receptor agonist buspirone on the blood glucose and pancreatic hormones in rats. , 1992, Japanese journal of pharmacology.
[15] M. Pompeiano,et al. Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. , 1994, Brain research. Molecular brain research.
[16] D. Murphy,et al. The serotonin agonist, M-chlorophenyl-piperazine, markedly increases levels of plasma catecholamines in the conscious rat , 1988, Neuropharmacology.
[17] G. Bagdy. Role of the hypothalamic paraventricular nucleus in 5-HT1A , 5-HT2A and 5-HT2C receptor-mediated oxytocin, prolactin and ACTH/corticosterone responses , 1995, Behavioural Brain Research.
[18] D. Laude,et al. Ganglionic transmission is a prerequisite for the adrenaline-releasing and hyperglycemic effects of 8-OH-DPAT. , 1990, European journal of pharmacology.
[19] P P Humphrey,et al. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). , 1994, Pharmacological reviews.
[20] J. Leysen,et al. Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors. , 1981, Life sciences.
[21] F. Chaouloff,et al. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat. , 1987, The Journal of pharmacology and experimental therapeutics.
[22] G. Bagdy,et al. Effect of 5-HT1C and 5-HT2 receptor stimulation on excessive grooming, penile erection and plasma oxytocin concentrations. , 1992, European journal of pharmacology.